Machine Learning Predicting Atrial Fibrillation as an Adverse Event in the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial — Ying X. Gue (2023) | RDL Network
Machine Learning Predicting Atrial Fibrillation as an Adverse Event in the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial
Article 2023 en
Authors
YG
Ying X. Gue
EC
Elon Correa
JT
John L.P. Thompson
Abstract
1 min read
The use of machine learning can prove useful in identifying novel cardiac risk factors. Our analysis has shown that "social factors," such as living alone, may disproportionately increase the risk of atrial fibrillation in the under-represented non-White patient group with heart failure, highlighting the need for more studies focusing on stratification of multiracial cohorts to better uncover the heterogeneity of atrial fibrillation.
Eduard Shantsila, Farhan Shahid, Yongzhong Sun, Jonathan J Deeks, Melanie Calvert, James P. Fisher, Paulus Kirchhof, Paramjit Gill, Professor Gregory Lip
Katarzyna Mitręga, Professor Gregory Lip, Beata Średniawa, Adam Sokal, Witold Streb, Karol Przyłudzki, Tomasz Zdrojewski, Łukasz Wierucki, Marcin Rutkowski, Piotr Bandosz, Jarosław Kaźmierczak, Tomasz Grodzicki, Grzegorz Opolski, Zbigniew Kalarus
Discussion(0)
No comments yet. Be the first to comment.